Print

Purpose

The purpose of this research is to develop DIPPer Academy, a parent-focused, mobile health (mHealth) behavioral intervention to promote glycemic control in young children.

Condition

Eligibility

Eligible Ages
Between 3 Years and 65 Years
Eligible Genders
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Parents of a young child who is between 3-5.99 years old and at least 6 months post T1D diagnosis - Parents who are English-speaking.

Exclusion Criteria

  • Parents of young children with evidence of type 2 diabetes or monogenic diabetes. - Parents with evidence of severe psychiatric disorder. - Parents of young children with a comorbid chronic illness (e.g., renal disease) that requires ongoing care beyond T1D. - Parents of young children with a history of anemia or medication use that may interact with glycemic control (e.g., systemic steroids).

Study Design

Phase
N/A
Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary Purpose
Prevention
Masking
None (Open Label)

Arm Groups

ArmDescriptionAssigned Intervention
Experimental
DIPPer Academy 		Parents randomized to this group will participate in the DIPPer Academy curriculum.
  • Behavioral: DIPPer Academy
    The DIPPer Academy curricula will build on treatment models guided by the Health Beliefs Model (HBM) and Social Cognitive Theory (SCT). The curricula includes video microlectures, personalize progress reports, and other features delivered via the internet.
Active Comparator
Standard of Care Control 		Parents randomized to this group will receive care as usual from their child's diabetes provider
  • Other: Standard of Care
    Parents in the standard of care control group will be instructed to manage their child's T1D as recommended by the diabetes team.

More Details

Status
Completed
Sponsor
University of Kansas Medical Center

Study Contact

Detailed Description

Because many young children with T1D have glucose levels that exceed targets, investigators need to develop efficacious, accessible, and readily disseminable interventions to help them to improve their glycemic control. To do this, the investigators need efficacious interventions that specifically address the challenges that parents of young children face in daily T1D management. Providers need mHealth interventions that minimize barriers that parents experience when trying to access face-to-face or in clinic interventions. Finally, interventions are needed that are packaged to be easily deployable by other diabetes centers. The investigator's proposed intervention, DIPPer Academy, will include all of these recommended advancements.

Notice

Study information shown on this site is derived from ClinicalTrials.gov (a public registry operated by the National Institutes of Health). The listing of studies provided is not certain to be all studies for which you might be eligible. Furthermore, study eligibility requirements can be difficult to understand and may change over time, so it is wise to speak with your medical care provider and individual research study teams when making decisions related to participation.